DRUG Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.70
Past Year
- $1.94
Growth Past 5yrs
-35.46%
Next Quarter
- $0.95
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$147.00
64.96% Upside
Mean Price Target
$119.55
34.15% Upside
Lowest Price Target
$72.00
-19.2% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Apr 13, 2026
Actual EPS vs Estimated EPS
DRUG Earnings Per Share (EPS) History
According to financial reports, DRUG (NYSE: DRUG) reported an actual EPS of $-0.7 for the quarter ending on Feb 12, 2026, compared to an estimated $-0.98, resulting in a -28.57% surprise. In the prior quarter (Dec 23, 2025), DRUG recorded an actual EPS of $-0.54323 with a -54.92% surprise. See DRUG's full earnings history.
Earnings History
EPS Surprise Factor Analysis
DRUG has experienced notable EPS surprises, with the latest quarter ending Feb 12, 2026 showing a -28.57% miss. Previously, the quarter ending Dec 23, 2025 recorded a -54.92% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Feb 12, 2026 | -0.7 | -0.98 | -28.57% |
| Dec 23, 2025 | -0.54323 | -1.205 | -54.92% |
| Aug 14, 2025 | -0.53 | -0.59 | -10.17% |
| May 15, 2025 | -0.29 | -0.39 | -25.64% |
| Feb 13, 2025 | 0.01 | -0.23 | -104.35% |
| Dec 30, 2024 | -0.12 | -0.44343 | -72.94% |
Frequently Asked Questions
Is DRUG stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given DRUG stock an average recommendation of
Buy. 11 analysts have given their ratings
to DRUG out of which
0 analysts have given strong buy call,
11 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$119.55 gives the stock implied upside
of roughly 34.15% over the next year or so.
What have analysts suggested for DRUG highest price target?
Analysts suggest DRUG's stock price would rise to a high of $147.00.
What is the lowest price target analysts expect for DRUG over the next year?
Within the next 12 months, analysts predict the DRUG stock price could move to $72.00.
What is the average target price for DRUG?
DRUG stock has an average analyst estimate of $119.55.
At its current price, how far is DRUG from its average target price?
DRUG shares are currently trading 34.15% above this price target.
What were DRUG’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.70 versus consensus estimates of - $0.98, and below the comparable year-ago quarter’s EPS of $0.01.
What are the current estimates for quarterly and annual earnings per share?
DRUG's forecasts by analysts estimating quarterly EPS at - $0.95 and - for the whole year.
What has DRUG's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for DRUG in the next five years, compared to growth rates of -35.46% in the past five years.